Bilateral endometriomas

In: Applied Radiology · 2019 · pp. 46–47 · doi:10.37549/ar2606 · W4285788991
article OA: hybrid CC0
⚙ AI-generated summary by qwen3.7-flash+body, 2026-09-29 ⓘ

Contrast-enhanced pelvic MRI reliably distinguishes endometriomas from other adnexal lesions using T2 shading, the T2 dark spot sign, and lack of internal enhancement to rule out malignant transformation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-29 · read from full text ⓘ

This case report describes a 34-year-old female with worsening dysmenorrhea and abnormal uterine bleeding, for whom transvaginal ultrasound revealed bilateral indeterminate ovarian cysts. Pelvic MRI with gadolinium contrast was utilized to characterize the lesions, identifying characteristic features such as T1 hyperintensity, T2 shading, and a T2 dark spot that confirmed the diagnosis of bilateral endometriomas. The authors highlight these specific imaging signs as reliable methods for distinguishing endometriomas from hemorrhagic cysts, dermoid cysts, and other adnexal masses, while also noting their utility in ruling out malignant transformation. This paper is centrally about endometriosis — specifically the radiological identification and characterization of endometriomas using contrast-enhanced MRI.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 4,237 characters · extracted from oa-html · 3 sections · click to expand

Discussion

Contrast-enhanced MRI of the pelvis can be useful to characterize indeterminate adnexal lesions. As demonstrated in this case, endometriomas have a characteristic appearance. Due to repeated cyclical hemorrhage and varying levels of deoxyhemoglobin and methemoglobin, endometriomas will appear hyperintense on T1-weighted sequences with varying levels of hypointensity on T2-weighted sequences. This has been described as the shading sign,1 and is characteristic of endometriomas, which more commonly show complete loss of signal intensity on T2-weighted images, or as hypointense layering fluid level. T2 shading is particularly useful in distinguishing between endometriomas and hemorrhagic cysts. Hemorrhagic cysts also appear hyperintense on T1-weighted images, but typically do not have T2 shading. Since they do not have repeated cyclical hemorrhage, the concentration and viscosity of hemorrhagic cysts is lower, and they are typically bright on T2-weighted images. Endometriomas can also be distinguished from hemorrhagic cysts by the presence of a T2 dark spot.2 Defined as a well-defined hypointense focus on T2-weighted images, the T2 dark spot is a marker of chronic hemorrhage and when present, highly specific for endometrioma. Rarely, endometriomas may under- go malignant transformation. Contrast-enhanced MRI, particularly with digital subtraction, is useful for identifying enhancing mural nodules, the most important finding for identifying malignant transformation.3 Interval increase in size or loss of T2 shading can also be seen. Wall enhancement is a normal finding associated with endometriomas. Other differential considerations include dermoid cysts, cystic neoplasm, and tubo-ovarian abscess. Dermoid cysts can be characterized by the presence of fat, manifesting as signal loss on fat-saturated sequences. Cystic neoplasms often have more soft tissue components with heterogeneous T1 signal that typically enhance.4 Abscess typically presents as a T1 hypointense lesion with T2 heterogeneous to hyperintense signal, with wall and surrounding soft tissue enhancement.5

Conclusion

Indeterminate adnexal lesions that cannot be diagnosed on ultrasound are often followed up with contrast-enhanced pelvic MRI for further characterization. T2 shading, presence of a T2 dark spot, persistent T1 hyperintensity on fat-saturated sequences, and lack of internal contrast enhancement can be used reliably distinguish endometriomas from hemorrhagic cysts, dermoid cysts, ovarian neoplasms, and tubo-ovarian abscess, as well as rule out malignant transformation.

References

- Glastonbury C. The shading sign.. Radiology. 2002;224(1):199-201. - Corwin M, Gerscovich E, Lamba R. Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign.. Radiology. 2014;271(1):126-132. - Takeuchi M, Matsuzaki K, Uehara H. Malignant transformation of pelvic endometriosis: MR imaging findings and pathologic correlation.. Radiographics. 2006;26(2):407-417. - Lee S. Radiological reasoning: imaging characterization of bilateral adnexal masses.. AJR Am J Roentgenol. 2006;187(3):S460-466. - Kim M, Rha S, Oh S. MR Imaging findings of hydrosalpinx: a comprehensive review.. Radiographics. 2009;29(2):495-507. Citation Bilateral endometriomas. Applied Radiology. 2019;48(5):46-47. doi:10.37549/AR2606. .

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK